IntrinsicIntrinsic
← Scroll for more →

Financial Statements — KBSX

Balance Sheet

(in millions USD)
MetricQ4 2026Q4 2025Q3 2025Q2 2025Q4 2024
Cash & Equivalents7.347.188.187.035.10
Short-term Investments----0.000.062.00
Accounts Receivable6.986.986.316.225.29
Inventory11.8111.8113.2213.5714.53
Total Current Assets27.4827.4929.4429.3326.66
Property, Plant & Equipment19.0419.0419.9921.0119.52
Intangible Assets4.834.834.935.035.14
Total Non-current Assets32.3433.4331.5733.7931.93
Total Assets59.8260.9261.0163.1258.58
Accounts Payable4.563.034.803.131.50
Short-term Debt--18.20----15.27
Total Current Liabilities34.6530.4232.6134.1522.11
Long-term Debt10.9629.1613.6511.7524.71
Total Non-current Liabilities15.6514.9517.6615.9913.47
Total Liabilities50.3145.3750.2750.1435.58
Retained Earnings(4.13)1.57(4.27)(2.64)3.05
Total Stockholder Equity9.3715.4310.6012.8222.83
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2025Q2 2025
Total Revenue12.5522.19
Cost of Revenue7.6311.98
Gross Profit4.9210.22
Research & Development0.340.70
Selling, General & Admin2.684.81
Total Operating Expenses5.8711.74
Operating Income(0.95)(1.53)
Pretax Income*(0.49)(5.75)
Tax Provision0.220.08
Net Income(0.72)(5.83)
Basic EPS(0.02)(0.13)
Diluted EPS(0.02)(0.13)
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ3 2025Q2 2025
Operating Cash Flow3.36(1.09)
Capital Expenditures0.380.12
Free Cash Flow*2.98(1.21)
Investing Cash Flow(0.43)(0.24)
Financing Cash Flow(2.27)0.21
← Scroll for more columns →

* Derived from reported values